drugset / Trial / NCT04917731
Botulinum Toxin Type A for Cold Intolerance Secondary to Digital Amputations and Replantations: A Pilot Study
RandomizedSingle-groupQuadruple-blindTreatment
Summary
Patients will be selected for cold intolerance after finger amputation or replantation. They will be given Botox or placebo dose as treatment and assessed over 3 months.
Timeline
- Start
- 2021-06-02
- Primary completion
- 2023-06-02
- Completion
- 2023-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Other |
Indications
No indication recorded.